XML 18 R9.htm IDEA: XBRL DOCUMENT v3.24.3
Restatement
9 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Restatement

NOTE 3 - Restatement

 

The Company determined that the previously filed March 31, 2024, financial statements were misstated. The financial statements failed to include all transactions that occurred within the nine months period ended March 31, 2024, and determined that the March 31, 2024, financial statements should be restated. The misstatement arose as the September 21, 2023, transaction to record the share issuance and acquisition of the Professional Promoter license, Production Lifetime rights, and Production and Stage Equipment were not reflected in the September 30, 2023, financial statements. The cumulative impact of correcting this misstatement is that the share issuance of 12,380,951 shares is reflected in the Statement of Stockholders Equity as outstanding as of March 31, 2024, increasing the total outstanding shares issued to 13,109,794, and the Balance Sheet reflects the acquisition of the non-current assets acquired in exchange for the shares. This resulted in an increase to total assets of $14,059,109 comprised of $13,098,000 and $1,058,209 related to the Professional Promoter license and Production Lifetime rights; and Production and Stage Equipment, respectively.